AMN 2017 Annual Report

57 A summary of stock option and SAR activity under the Stock Option Plan and the Equity Plan and Other Plans are as follows: Stock Option Plan Equity Plan and Other Plans Number Outstanding Weighted- Average Exercise Price per Share Number Outstanding Weighted- Average Exercise Price per Share Outstanding at December 31, 2014 245 $ 14.93 948 $ 10.61 Granted — $ — — $ — Exercised (245) $ 14.93 (615) $ 10.79 Canceled/forfeited/expired — $ — (1) $ 24.95 Outstanding at December 31, 2015 — $ — 332 $ 10.26 Granted — $ — — $ — Exercised — $ — (44) $ 13.69 Canceled/forfeited/expired — $ — (2) $ 18.03 Outstanding at December 31, 2016 — $ — 286 $ 9.67 Granted — $ — — $ — Exercised — $ — (24) $ 18.85 Canceled/forfeited/expired — $ — — $ — Outstanding at December 31, 2017 — $ — 262 $ 8.81 Vested and expected to vest at December 31, 2017 — $ — 262 $ 8.81 Exercisable at December 31, 2017 — $ — 262 $ 8.81 As of December 31, 2017, all SARs were fully vested, and there were no stock options outstanding. The total intrinsic value of stock options and SARs exercised was $555, $877 and $10,505 for 2017, 2016 and 2015, respectively. At December 31, 2017 and 2016, the total intrinsic value of stock options and SARs outstanding and exercisable was $10,674 and $8,247, respectively. Share-Based Compensation Total share-based compensation expense for the years ended December 31, 2017, 2016 and 2015 was as follows: Years Ended December 31, 2017 2016 2015 Share-based employee compensation, before tax $ 10,237 $ 11,399 $ 10,284 Related income tax benefits (3,985) (4,423) (3,990) Share-based employee compensation, net of tax $ 6,252 $ 6,976 $ 6,294 (12) Commitments and Contingencies (a) Legal From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. These matters typically relate to professional liability, tax, payroll, contract, competitor disputes and employee-related matters and include individual and collective lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment practices. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to services provided by the Company’s healthcare professionals. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. The most significant